It minimises material investment in the early stages of a research project
Regulatory Status in 2026 BPC-157 has no FDA approval for human therapeutic use in the United States and is not eligible for compounding under 503B rules
The discovery that NNMT expression is dramatically elevated in adipose tissue of obese humans and animal models, and that NNMT inhibition or knockdown prevents diet-induced obesity and improves metabolic health, has catalyzed intense research interest in NNMT as a therapeutic target for obesity, metabolic syndrome, and related conditions
BPC-157 & TB-500 Blend $95.00 BPC-157 & TB-500 Blend
Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: a natively unfolded protein
As interest in GLP-1 receptor biology has expanded, so has the demand for well-characterized, high-purity semaglutide compounds that can support reproducible experimental results